Summary
Urapidil (URA) is used to treat acute hypertension in patients with coronary artery disease, but the effect of URA on the performance of ischemic myocardium has not yet been investigated. The present study was intended to assess the function of ischemic myocardium following URA administration. In eight anesthetized (piritramide) open-chest dogs systolic contraction (dL) and end-diastolic length (edL) of myocardium supplied by the left descending (LAD) and circumflex (LCA) coronary arteries were measured by sonomicrometry simultaneously with aortic pressure (AoP), left ventricular end-diastolic pressure (LVedP), heart rate (HR), stroke volume (SV), and LAD-flow (QLAD). QLAD was reduced by LAD stenosis to about 50% of control, decreasing dLLAD by 55%. Concomitantly, edLLAD increased by about 9% and LVedP by 22%, whereas AoP decreased by 5%. Then, URA was given i.v. (0.25+0.25+0.50+1.0 mg/kg) in 15-min intervals. Following URA, the performance of the non-ischemic area was not systematically affected, but dLLAD increased by about 50%. This could neither be related to the significant reduction in afterload (AoP: −8%), nor to an increase in preload (LVedP and edLLAD did not change significantly), nor to an improved oxygen supply via the LAD (QLAD even decreased), although an increased collateral flow from the LCA could not be excluded. The increase in systolic shortening correlated very closely to a decrease in heart rate (r=−0.92). It is concluded that the improved function of ischemic myocardium following urapidil resulted from a reduced oxygen demand in consequence to the decrease in heart rate.
Similar content being viewed by others
References
Barankay A, Göb E, Richter JA (1981) Treatment of hypertension in coronary bypass surgery, clinical experience with urapidil. Arzneim Forsch Drug Res 31:849–852
Fozard JR, Mir AK (1987) Are 5-HT receptors involved in the antihypertensive effects of urapidil? Brit J Pharmacol 90:24P
Frank O (1895) Zur Dynamik des Herzmuskels. Z Biol 32:370–437
Franke N, Schmucker P, Vogel H, Lühr H (1982) Veränderungen der Hämodynamik und des myokardialen Sauerstoffverbrauchs bei intraoperativer Drucksenkung mit Urapidil. In: Kaufmann W, Bruckschen EG (eds) Urapidil. Darstellung einer neuen antihypertensiven Substanz. Excerpta Medica Amsterdam, pp 113–118
Freissmuth M, Tuisl E, Steurer G, Schütz W (1984) Interaction of the antihypertensive drug urapidil with cardiac beta0adrenoceptors in vitro. European J Pharmacol 104:169–172
Floer KL, Hagl S, Heimisch W, Hall D, Rudolph W (1980) Verbesserung der Funktion akut ischämischer Myokardbezirke unter dem Einfluß von Isosorbiddinitrat in der Kombination mit der intraaortalen Ballongegenpulsation. In: Rudolph W, Schrey A (eds) Nitrate II. Wirkung auf Herz und Kreislauf. Urban & Schwarzenberg Verlag, München, pp 333–336
Gillis A, Kellar KJ, Quest JA, Namath IJ, Martino-Barrows A, Hill K, Gatti PJ, Dretchen K (1988) Experimental studies on the neurocardiovascular effects of urapidil. Drugs 35, Suppl 6:20–33
Heimisch W, Hagl S, Gebhardt K, Meisner H, Mendler N, Sebening F (1981) Direct measurement of cyclic changes in regional wall geometry in the left ventricle of the dog. Innov Tech Biol Med 2:487–501
Heimisch W, Hagl S, Mendler N, Schad H, Sebening F (1988) Experimental studies on acute coronary stenosis: pathophysiology of hemodynamics and mechanics of the ischemic and nonischemic myocardium. Thorac Cardiovasc Surgeon 36, Suppl 1:93
Helfant RH, Bamanathan KB, Bodenheimer MM, Banka VS (1980) Comparative effects of nitroglycerin and nitroprusside on regional coronary flow and contraction after partial coronary occlusion. In: Rudolph W, Schrey A (eds) Nitrate II. Urban & Schwarzenberg, München Wien Baltimore, pp 110–118
Hess W, Schulte-Sasse U, Tarnow J, Veit S (1985) Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery. Europ J Anesth 2:21–27
Isoyama S, Maruyama Y, Ashikawa K, Sato S, Suzuki H, Watanabe J, Shimizu Y, Ino-Oka E, Takishima T (1983) Effects of afterload reduction on global left ventricular and regional myocardial functions in the isolated canine heart with stenosis of a coronary arterial branch. Circulation 67:139–147
Junger H, van Deyk K, Kopp M (1982) Hämodynamik unter antihypertensiver Therapie mit Urapidil und Nitroprussid-Natrium. In: Kaufmann W, Bruckschen EG (eds) Urapidil. Darstellung einer neuen antihypertensiven Substanz. Excerpta Medica. Amsterdam, pp 139–146
Kellar KJ, Quest JA, Spera AC, Buller A, Conforti A, Dias-Souza J, Gillis RA (1984) Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial blood pressure, and heart rate in experimental animals. Am J Med 77(4A):87–95
Kolassa N, Beller KD, Sanders KH (1989) Evidence for the interaction of urapidil with 5-HT-1A receptors in the brain leading to a decrease in blood pressure. Am J Cardiol 63:36C-39C
Lekven J, Kiil F (1975) Myocardial function in general and regional left ventricular ischemia in dogs at control and high aortic blood pressure. Cardiovasc Res 9:373–383
Luft FC, Veelken R, Becker H, Ganten D, Lang RE, Unger T (1986) Effects of clondine, and prazosin on sympathetic tone in conscious rats. Hypertension 8:303–311
Maier W, Hagl S, Heimisch W, Meisner H Mendler N, Sebening F (1984) β1-selektive/nichtselektive β-Rezeptorenblockade: Die Wirkung auf die Funktion des ischämischen Myokards. In: Lohmann FW (ed) β-Rezeptorenblockade: Die klinische Bedeutung der β1-Selektivität. Verlag für angewandte Wissenschaften. München, pp 79–97
Rassier ME, Shebuski RJ, Zimmermann BG (1986) beta-1-adrenoceptor antagonism by urapidil prior to and after the alpha-2-antagonist rauwolscine in anesthetized dogs. Europ J Pharmacol 122:37–43
Sanders KH, Jurna I (1985) Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anesthetized rats and cats. Europ J Pharmacol 110:181–190
Sanders KH, Kilian U, Kolassa N, Schoetensack W (1985) Influence of urapidil on alpha- and beta-adrenoceptors in pithed rats. J Autonom Pharmacol 5:307–316
Schad H, Heimisch W, Kalke Y, Mendler N (1988) Effect of heart rate (HR) changes by vagal stimulation on normally perfused and ischemic myocardium in anaesthetized dogs. Pflügers Arch 411, Suppl 1:R34
Schad H, Heimisch W, Mendler N (1988) Effect of a critical coronary artery stenosis on the function of the depending myocardial area in anaesthetized dogs. Pflügers Arch 412, Suppl 1:R32
Schoetensack W (1982) Tierexperimentelle Untersuchungen über die Wirkung und Wirkungsweise sowie Toxikologie von Urapidil. In: Kaufmann W, Bruckschen EG (eds) Urapidil. Excerpta Medica, Amsterdam, pp 34–47
Schümann HJ, Bielefeld FW (1986) The effect of urapidil on cardiac alpha- and beta-adrenoceptors. Arzneim Forsch Drug Res 36:1471–1476
Vatner SF (1980) Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 47:201–207
Vatner SF (1985) Regulation of coronary resistance vessels and large coronary arteries. Am J Cardiol 56:16E-22E
Verberne AJM, Rand MJ (1984) Pharmacological activities of the antihypertensive drug urapidil in the rat. Clin Exp Pharmacol Physiol 11:407–412
Verberne AJM, Rand MJ (1985) Effect of urapidil on beta-adrenoceptors of rat atria. European J Pharmacol 108:193–195
Wang RYC, Chow JSF, Chan KH, Pan HYM, Wong RPY (1984) Acute haemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failure. European Heart J 5:745–751
Zeigler DW, Shebuski RJ, Zimmerman BG (1984) Central and peripheral cardiovascular actions of urapidil in normotensive and Goldblatt hypertensive animals. Am J Med 77(4A):81–86
Zeigler DW, Zimmerman BG (1985) Comparison of effects of urapidil and prazosin on vascular influence of circulating and neuronally released catecholamines in canine muscle vascular bed. J Cardiovasc Pharmacol 7:1020–1026
van Zwieten PA, Mathy MJ, Thoolen MJM, Wilffert B, de Jonge A, Timmermans PBM (1984) Effect of urapidil on blood pressure and adrenoceptors in various animal models. J Hypertension 2, Suppl 3:539–541
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schad, H., Heimisch, W., Barankay, A. et al. Effect of urapidil on the performance of ischemic myocardium in anesthetized dogs. Basic Res Cardiol 85, 270–278 (1990). https://doi.org/10.1007/BF01907115
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01907115